Biotechnology Industry

Below are the top biotechnology stocks on the NYSE in terms of revenue estimate for the current year. Analysts expect Charles River Laboratories International (NYSE: CRL) to post revenue of $1.14 billion for the year ending December, 2012. Charles River Laboratories' trailing-twelve-month ROE is...

Below are the top mid-cap biotechnology stocks on the NYSE and the NASDAQ in terms of cash. Illumina (NASDAQ: ILMN) had $1.27 billion in total cash and $815.97 million in total debt for the latest quarter. Onyx Pharmaceuticals (NASDAQ: ONXX) had $599.99 million in total cash and $165.64 million...

Below are the top small-cap biotechnology stocks on the NYSE and the NASDAQ in terms of cash. Dendreon Corp (NASDAQ: DNDN) had $497.54 million in total cash and $573.82 million in total debt for the latest quarter. ViroPharma Inc (NASDAQ: VPHM) had $473.36 million in total cash and $155.46...

Below are the top biotechnology stocks on the NASDAQ in terms of PEG ratio. Cadence Pharmaceuticals Inc (NASDAQ: CADX) has a PEG ratio of 0.02. CADX's trailing-twelve-month revenue is $10.81 million. Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) has a PEG ratio of 0.06. VRTX's trailing-...

Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at Gilead Sciences Inc (NASDAQ: GILD) is 47.98%. GILD's ROE for the same period is 45.47%. The trailing-twelve-month operating margin at Biogen Idec...

Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of earnings per share. The trailing-twelve-month earnings per share at Biogen Idec Inc (NASDAQ: BIIB) is $4.80. BIIB's PEG ratio is 1.88. The trailing-twelve-month earnings per share at Amgen Inc (NASDAQ: AMGN)...

Below are the top biotechnology stocks on the NYSE in terms of return on equity. The trailing-twelve-month return on equity at ShangPharma Corporation (NYSE: SHP) is 13.44%. SHP's PEG ratio is 0.42. The trailing-twelve-month return on equity at Medicis Pharmaceutical Corp (NYSE: MRX) is 12.43%....

Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio. Gilead Sciences Inc (NASDAQ: GILD) has a PEG ratio of 0.63. GILD's trailing-twelve-month operating margin is 48.78%. Celgene Corporation (NASDAQ: CELG) has a PEG ratio of 0.73. CELG's trailing-...

Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at Gilead Sciences Inc (NASDAQ: GILD) is 52.04%. GILD's PEG ratio is 0.70. The trailing-twelve-month operating margin at Amgen Inc (NASDAQ: AMGN) is...

Below are the top mid-cap biotechnology stocks on the NYSE and the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at Techne Corporation (NASDAQ: TECH) is 57.32%. TECH's ROE for the same period is 21.58%. The trailing-twelve-month operating margin at Cephalon Inc (...

Below are the top small-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio. PDL BioPharma Inc (NASDAQ: PDLI) has a PEG ratio of 0.27. PDLI's trailing-twelve-month operating margin is 89.34%. Exelixis Inc (NASDAQ: EXEL) has a PEG ratio of 0.33. EXEL's trailing-twelve-month...

Below are the top biotechnology stocks on the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at Gilead Sciences Inc (NASDAQ: GILD) is 51.77%. GILD’s operating margin for the same period is 53.40%. The trailing-twelve-month return on equity at Talecris...

Below are the top biotechnology stocks on the NYSE and the NASDAQ in terms of revenue estimates. Amgen Inc (NASDAQ: AMGN) is expected to generate $15.10 billion of revenue in the current year. Analysts at Argus upgraded AMGN from “hold” to “buy.” Gilead Sciences Inc (NASDAQ: GILD) is likely to...

While the World Cup Kicks off in South Africa, biotech investors are having their own world class event. The American Society of Clinical Oncology (ASCO) kicked off this June 4th and will run until today. This is the most important meeting for the biotech sector and is attended by doctors and...

Below are the top 5 biotechnology stocks on the NASDAQ in terms of profit margins. QLT (NASDAQ: QLTI) has the trailing-twelve-month profit margins of 230.56%. QLTI’s quarterly earnings growth stands at 161.60% year-over-year. PDL BioPharma Inc (NASDAQ: PDLI) has the trailing-twelve-month profit...